|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/20 | |
| A61P 1/10 | |||
| A61K 33/42 | |||
| A61K 31/765 |
| (11) | Number of the document | 1682098 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04819530.9 |
| Date of filing the European patent application | 2004-11-17 | |
| (97) | Date of publication of the European application | 2006-07-26 |
| (45) | Date of publication and mention of the grant of the patent | 2016-05-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2004/038220 |
| Date | 2004-11-17 |
| (87) | Number | WO 2005/051361 |
| Date | 2005-06-09 |
| (30) | Number | Date | Country code |
| 523142 P | 2003-11-19 | US |
| (72) |
SKIENDZIELEWSKI, Stephen, US
ROSE, Martin, US
DO, Ngoc, US
|
| (73) |
Salix Pharmaceuticals, Inc.,
400 Somerset Corporate Boulevard, Bridgewater, NJ 08807,
US
|
| (54) | COLONIC PURGATIVE COMPOSITION WITH SOLUBLE BINDING AGENT |
| COLONIC PURGATIVE COMPOSITION WITH SOLUBLE BINDING AGENT |